Evidence map›Paper›PMID 40654723›Full record

ArticlebioRxiv : the preprint server for biology2025

A human and mouse subpopulation of senescent β-cells induces pathologic dysfunction through targetable paracrine signaling.

Kanako Iwasaki, Priscila Carapeto, Cristian Abarca, Francesko Hela, Stephanie Sanjines, Sebastian Pena, Sandra Le, Hui Pan, Christopher Cahill, Ayush Midha and 15 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Kanako IwasakiJoslin Diabetes Center/Harvard Medical School. Boston, MA.ORCID 0000-0003-1671-3980
Priscila CarapetoJoslin Diabetes Center/Harvard Medical School. Boston, MA.ORCID 0000-0002-8987-9116
Cristian AbarcaJoslin Diabetes Center/Harvard Medical School. Boston, MA.ORCID 0000-0003-1968-2761
Francesko HelaJoslin Diabetes Center/Harvard Medical School. Boston, MA.ORCID 0000-0002-9977-1221
Stephanie SanjinesJoslin Diabetes Center/Harvard Medical School. Boston, MA.
Sebastian PenaJoslin Diabetes Center/Harvard Medical School. Boston, MA.
Sandra LeJoslin Diabetes Center/Harvard Medical School. Boston, MA.
Hui PanJoslin Diabetes Center/Harvard Medical School. Boston, MA.
Christopher CahillJoslin Diabetes Center/Harvard Medical School. Boston, MA.
Ayush MidhaJoslin Diabetes Center/Harvard Medical School. Boston, MA.ORCID 0000-0002-3363-3918
Juliana Alcoforado DinizThe Jackson Laboratory for Genomic Medicine, Farmington, CT.
Dylan BakerThe Jackson Laboratory for Genomic Medicine, Farmington, CT.
Sergii DomanskyiThe Jackson Laboratory for Genomic Medicine, Farmington, CT.ORCID 0000-0002-6847-6019
Sara EspinozaCenter of Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
Alejandro PenaUT Health, San Antonio, TX.
Francisco G CigarroaUT Health, San Antonio, TX.
Jillian L WoolworthUT Health, San Antonio, TX.
Jeffrey H ChuangThe Jackson Laboratory for Genomic Medicine, Farmington, CT.ORCID 0000-0002-3298-2358
Vesna D GarovicDepartment of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN.
James L KirklandCenter of Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
Tamar TchkoniaCenter of Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
Nicolas MusiCenter of Advanced Gerotherapeutics, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
George A KuchelUConn Center on Aging, UConn Health, Farmington, CT.ORCID 0000-0001-8387-7040
Paul RobsonThe Jackson Laboratory for Genomic Medicine, Farmington, CT.ORCID 0000-0002-0191-3958
Cristina Aguayo-MazzucatoJoslin Diabetes Center/Harvard Medical School. Boston, MA.ORCID 0000-0001-5402-1382

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
The Human Islet Distribution Coordinating Center (UC4)UC4DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI EVANS-MOLINA, CARMELLA, NILAND, JOYCE CAROL · 2012 to 2017
$25.6M
The KAPP-Sen Tissue Mapping Center CollaborativeU54AG075941 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GAROVIC, VESNA D, KUCHEL, GEORGE A · 2021 to 2025
$13.8M
Effect of Aging on Preadipocyte DifferentiationR37AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 2016 to 2025
$6.6M
UAB STEP-UP: Promoting Diversity through Team Mentored Research ExperiencesR25DK113652 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FOUAD, MONA N., GARVEY, W TIMOTHY · 2017 to 2024
$2.5M
Elucidating and targeting beta-cell senescence and its SASPR01DK132535 · NIDDK · JOSLIN DIABETES CENTER · PI Cristina Aguayo-Mazzucato · 2022 to 2026
$2.1M
Joslin-BIDMC Postbac Program in Diabetes and MetabolismR25DK140752 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 2024 to 2026
$1.2M
NIA NIH HHS R37 AG013925NIA NIH HHS U54 AG075941NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK132535NIDDK NIH HHS R25 DK113652NIDDK NIH HHS R25 DK140752NIDDK NIH HHS UC4 DK098085
6 · The paper itself

Abstract

Cellular senescence is a stress response mechanism marked by irreversible growth arrest, upregulation of antiapoptotic pathways, loss of cellular function, and remodelling of the cellular secretory profile. In both humans and mice, pancreatic β-cells undergo senescence with age and insulin resistance. Targeted removal of senescent cells in mouse models of diabetes improves glucose homeostasis, demonstrating the role β-cell senescence in diabetes progression. In contrast, β-cell senescence also promotes immune surveillance, promoting β-cell survival and function. Thus, a better understanding of senescent cells' phenotypic and functional heterogeneity is needed to develop effective therapeutic strategies. Herein, we show that subpopulations of senescent β-cells in mice and humans, which were identified through the expression of

Identifiers

PMID40654723
PMCPMC12247971

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.